EyePoint Market Cap

EyePoint has a market cap or net worth of $1.05 billion as of February 5, 2026. Its market cap has increased by 106.44% in one year.

Market Cap

1.05B

Enterprise Value

912.03M

1-Year Change

106.44%

Ranking

#2529

Market Cap Chart

Since January 27, 2005, EyePoint's market cap has increased from $388.60M to $1.05B, an increase of 171.20%. That is a compound annual growth rate of 4.86%.

Market Cap History

Date	Market Cap	% Change
Feb 3, 2026	1.06B	-29.94%
Dec 31, 2025	1.51B	197.44%
Dec 31, 2024	508.50M	-37.68%
Dec 29, 2023	816.00M	583.99%
Dec 30, 2022	119.30M	-66.13%
Dec 31, 2021	352.20M	273.09%
Dec 31, 2020	94.40M	-43.68%
Dec 31, 2019	167.60M	-6.53%
Dec 31, 2018	179.30M	266.67%
Dec 29, 2017	48.90M	-16.27%
Dec 30, 2016	58.40M	-58.82%
Dec 31, 2015	141.80M	17.58%
Dec 31, 2014	120.60M	12.71%
Dec 31, 2013	107.00M	279.43%
Dec 31, 2012	28.20M	22.08%
Dec 30, 2011	23.10M	-75.61%
Dec 31, 2010	94.70M	44.14%
Dec 31, 2009	65.70M	281.98%
Dec 31, 2008	17.20M	-70.19%
Dec 31, 2007	57.70M	-25.93%
Dec 29, 2006	77.90M	-62.73%
Dec 30, 2005	209.00M	-46.22%
Jan 27, 2005	388.60M	-

View and export this data all the way back to 2005. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Aktis Oncology	1.10B
MoonLake Immunotherapeutics	1.10B
Phathom Pharmaceuticals	1.08B
ORIC Pharmaceuticals	1.07B
Vir Biotechnology	1.07B
Zenas BioPharma	1.06B
AbCellera Biologics	1.05B
Iovance Biotherapeutics	1.05B

Market Cap Rankings